Research
DeepTNR: predicting tumor drug sensitivity from spatial transcriptomics with deep graph contrastive and transfer learning
Nature ·
The Brief
- A paper titled DeepTNR describes a method for predicting tumour drug sensitivity from spatial transcriptomics data.
- The approach combines deep graph contrastive learning with transfer learning.
- The source is a nature.com subject-feed listing dated 2026-11-12 and gives no summary, so performance and validation details are unknown.
Why it matters
It proposes a computational link between spatial gene-expression maps of tumours and predicted drug response, which could interest cancer and computational biology researchers. Its practical value depends on validation results that the source does not provide.
Who’s affected
- cancer researchers
- computational biologists
- #spatial transcriptomics
- #drug sensitivity
- #graph contrastive learning
- #transfer learning
- #cancer